Terms: = Thyroid cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Diagnosis
5 results:
1. Second primary cancers in people who had cancer as children: an Australian Childhood cancer Registry population-based study.
Youlden DR; Baade PD; Green AC; Valery PC; Moore AS; Aitken JF
Med J Aust; 2020 Feb; 212(3):121-125. PubMed ID: 31743457
[TBL] [Abstract] [Full Text] [Related]
2. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
[TBL] [Abstract] [Full Text] [Related]
3. Medullary thyroid cancer: are practice patterns in the United States discordant from American thyroid Association guidelines?
Panigrahi B; Roman SA; Sosa JA
Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
[TBL] [Abstract] [Full Text] [Related]
4. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract] [Full Text] [Related]
5. Carcinoma showing thymus-like element (CASTLE) of thyroid: combined modality treatment in 3 patients with locally advanced disease.
Chow SM; Chan JK; Tse LL; Tang DL; Ho CM; Law SC
Eur J Surg Oncol; 2007 Feb; 33(1):83-5. PubMed ID: 17085008
[TBL] [Abstract] [Full Text] [Related]
